Safinamide as Add-On Therapy to Levodopa in Mid- to Late-Stage Parkinson’s Disease Fluctuating Patients: Post hoc Analysesof Studies 016 and SETTLE

Background: Studies 016 and SETTLE showed that safinamide was safe and effective as adjunct therapy in patients with advanced Parkinson’s disease (PD) and motor fluctuations. The addition of safinamide to a stable dose of levodopa alone or with other antiparkinsonian medications significantly increa...

Descripción completa

Detalles Bibliográficos
Autores principales: Cattaneo, Carlo, Sardina, Marco, Bonizzoni, Ermino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2016
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927927/
https://www.ncbi.nlm.nih.gov/pubmed/26889632
http://dx.doi.org/10.3233/JPD-150700

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927927/
https://www.ncbi.nlm.nih.gov/pubmed/26889632
http://dx.doi.org/10.3233/JPD-150700

Ejemplares similares